Drawing for CONTINUITYRX

USPTO serial 50034747

CONTINUITYRX

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with CONTINUITYRX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gary Tannenbaum

Gary Tannenbaum The Tannenbaum Law Group LLC600 West Germantown PikeSuite 400Plymouth Meeting, PA 19462

Goods and services

ClassDescriptionStatusFirst use
035Administration and coordination of prescription medication fulfillment programs for injured employees; coordinating prescription fulfillment and delivery services between patients, prescribing healthcare providers, mail-order pharmacies, and retail pharmacies; pharmacy benefit management services for workers' compensation patients; business administration of medication fulfillment programs; providing prescription drug cost-management services, namely, reviewing prescribed medications to identify potential cost-saving opportunities. Medication therapy management services for workers' compensation patients; medication therapy review and drug utilization review services; monitoring patient medication adherence; providing medication-related counseling and clinical outreach to patients; monitoring medication therapies for potential interactions, contraindications, allergies, and formulary compliance.ACTIVEJul 1, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 27, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 5, 2026NWAPNEW APPLICATION ENTERED—
Aug 5, 2026MAFRAPPLICATION FILING RECEIPT MAILED—

Frequently asked questions

Related guidance